Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Wallis

Showing results (161-170 of 189) with videos related to

Pageof 19
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2012
Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategiesRaph L Hamers, Kim C E Sigaloff, Annemarie M Wensing, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 13, 2020
Brief Report: Sex Differences in Outcomes for Individuals Presenting for Third-Line Antiretroviral TherapyCatherine Godfrey, Michael D Hughes, Justin Ritz, et al.
AIDS (London, England)|March 24, 2012
Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settingsJohn A Bartlett, Heather J Ribaudo, Carole L Wallis, et al.
AIDS (London, England)|February 21, 2012
Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trialSarah B Lorenzana, Michael D Hughes, Beatriz Grinsztejn, et al.
The Journal of Antimicrobial Chemotherapy|January 23, 2019
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353Amesika N Nyaku, Lu Zheng, Roy M Gulick, et al.
Leukemia|July 29, 2017
Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophiliaM Jawhar, N Naumann, M Knut, et al.
The Lancet. Infectious Diseases|November 1, 2011
Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort studyRaph L Hamers, Rob Schuurman, Kim C E Sigaloff, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2019
Diverse Human Immunodeficiency Virus-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited SettingsCarole L Wallis, Michael D Hughes, Justin Ritz, et al.
The Lancet. Infectious Diseases|August 2, 2011
HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational studyRaph L Hamers, Carole L Wallis, Cissy Kityo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2022
High Asymptomatic Carriage With the Omicron Variant in South AfricaNigel Garrett, Asa Tapley, Jessica Andriesen, et al.
Pageof 19

Showing results (161-170 of 189) with videos related to

Sort By:
Pageof 19
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2012
Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategiesRaph L Hamers, Kim C E Sigaloff, Annemarie M Wensing, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 13, 2020
Brief Report: Sex Differences in Outcomes for Individuals Presenting for Third-Line Antiretroviral TherapyCatherine Godfrey, Michael D Hughes, Justin Ritz, et al.
AIDS (London, England)|March 24, 2012
Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settingsJohn A Bartlett, Heather J Ribaudo, Carole L Wallis, et al.
AIDS (London, England)|February 21, 2012
Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trialSarah B Lorenzana, Michael D Hughes, Beatriz Grinsztejn, et al.
The Journal of Antimicrobial Chemotherapy|January 23, 2019
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353Amesika N Nyaku, Lu Zheng, Roy M Gulick, et al.
Leukemia|July 29, 2017
Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophiliaM Jawhar, N Naumann, M Knut, et al.
The Lancet. Infectious Diseases|November 1, 2011
Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort studyRaph L Hamers, Rob Schuurman, Kim C E Sigaloff, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2019
Diverse Human Immunodeficiency Virus-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited SettingsCarole L Wallis, Michael D Hughes, Justin Ritz, et al.
The Lancet. Infectious Diseases|August 2, 2011
HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational studyRaph L Hamers, Carole L Wallis, Cissy Kityo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2022
High Asymptomatic Carriage With the Omicron Variant in South AfricaNigel Garrett, Asa Tapley, Jessica Andriesen, et al.
Pageof 19